Wilkins Investment Counsel Inc. increased its holdings in Express Scripts Holding Company (NASDAQ:ESRX) by 0.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 119,166 shares of the company’s stock after purchasing an additional 830 shares during the quarter. Express Scripts Holding accounts for 2.4% of Wilkins Investment Counsel Inc.’s holdings, making the stock its 17th biggest position. Wilkins Investment Counsel Inc.’s holdings in Express Scripts Holding were worth $7,608,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in ESRX. Pzena Investment Management LLC bought a new stake in shares of Express Scripts Holding in the 2nd quarter worth approximately $181,234,000. Renaissance Technologies LLC raised its holdings in shares of Express Scripts Holding by 9,353.3% in the 1st quarter. Renaissance Technologies LLC now owns 1,308,239 shares of the company’s stock worth $86,226,000 after purchasing an additional 1,294,400 shares in the last quarter. Baupost Group LLC MA bought a new stake in shares of Express Scripts Holding in the 1st quarter worth approximately $80,978,000. Veritas Asset Management LLP raised its holdings in shares of Express Scripts Holding by 13.2% in the 2nd quarter. Veritas Asset Management LLP now owns 8,192,572 shares of the company’s stock worth $523,014,000 after purchasing an additional 952,249 shares in the last quarter. Finally, Ameriprise Financial Inc. raised its holdings in shares of Express Scripts Holding by 17.2% in the 1st quarter. Ameriprise Financial Inc. now owns 5,028,552 shares of the company’s stock worth $331,430,000 after purchasing an additional 736,151 shares in the last quarter. Institutional investors and hedge funds own 88.69% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Wilkins Investment Counsel Inc. Grows Position in Express Scripts Holding Company (ESRX)” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another site, it was copied illegally and republished in violation of international trademark & copyright law. The original version of this article can be accessed at https://www.thecerbatgem.com/2017/09/28/wilkins-investment-counsel-inc-grows-position-in-express-scripts-holding-company-esrx.html.

ESRX has been the topic of a number of research reports. Jefferies Group LLC set a $72.00 target price on shares of Express Scripts Holding and gave the stock a “buy” rating in a report on Tuesday, August 29th. ValuEngine downgraded shares of Express Scripts Holding from a “buy” rating to a “hold” rating in a report on Friday, June 2nd. Needham & Company LLC initiated coverage on shares of Express Scripts Holding in a report on Friday, July 21st. They issued a “hold” rating on the stock. Cowen and Company reiterated an “outperform” rating and issued a $83.00 target price on shares of Express Scripts Holding in a report on Friday, June 9th. Finally, Royal Bank Of Canada initiated coverage on shares of Express Scripts Holding in a report on Tuesday, September 19th. They issued a “sector perform” rating and a $68.00 target price on the stock. Four investment analysts have rated the stock with a sell rating, fourteen have assigned a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. Express Scripts Holding currently has an average rating of “Hold” and a consensus target price of $70.09.

Express Scripts Holding Company (NASDAQ:ESRX) opened at 62.96 on Thursday. The company’s 50-day moving average is $61.81 and its 200-day moving average is $62.96. Express Scripts Holding Company has a 12 month low of $57.80 and a 12 month high of $77.50. The stock has a market capitalization of $36.36 billion, a P/E ratio of 10.93 and a beta of 0.88.

Express Scripts Holding (NASDAQ:ESRX) last announced its earnings results on Tuesday, July 25th. The company reported $1.73 EPS for the quarter, topping the consensus estimate of $1.71 by $0.02. The firm had revenue of $25.35 billion for the quarter, compared to the consensus estimate of $25.52 billion. Express Scripts Holding had a net margin of 3.50% and a return on equity of 25.58%. The business’s quarterly revenue was up .5% on a year-over-year basis. During the same period last year, the company posted $1.57 EPS. Equities analysts anticipate that Express Scripts Holding Company will post $6.99 earnings per share for the current year.

In other Express Scripts Holding news, VP Everett Neville sold 1,163 shares of the firm’s stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $61.48, for a total transaction of $71,501.24. Following the sale, the vice president now directly owns 18,232 shares in the company, valued at approximately $1,120,903.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, VP Phyllis S. Anderson sold 578 shares of the firm’s stock in a transaction that occurred on Friday, September 8th. The stock was sold at an average price of $63.13, for a total transaction of $36,489.14. Following the sale, the vice president now owns 10,530 shares in the company, valued at $664,758.90. The disclosure for this sale can be found here. Insiders have sold a total of 5,641 shares of company stock worth $357,317 over the last 90 days. Corporate insiders own 0.68% of the company’s stock.

About Express Scripts Holding

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Stock Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related stocks with our FREE daily email newsletter.